Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27-Stimulated Cytotoxicity of NK Cells.

Zhou WJ, Chang KK, Wu K, Yang HL, Mei J, Xie F, Li DJ, Li MQ.

Neoplasia. 2018 Jan;20(1):69-79. doi: 10.1016/j.neo.2017.11.003. Epub 2017 Dec 1.

2.

No patient left behind: The promise of immune priming with epigenetic agents.

Carter CA, Oronsky BT, Roswarski J, Oronsky AL, Oronsky N, Scicinski J, Lybeck H, Kim MM, Lybeck M, Reid TR.

Oncoimmunology. 2017 Aug 30;6(10):e1315486. doi: 10.1080/2162402X.2017.1315486. eCollection 2017. Review.

3.

Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis.

Mou H, Moore J, Malonia SK, Li Y, Ozata DM, Hough S, Song CQ, Smith JL, Fischer A, Weng Z, Green MR, Xue W.

Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3648-3653. doi: 10.1073/pnas.1620861114. Epub 2017 Mar 20.

4.

Ras oncogene-mediated progressive silencing of extracellular superoxide dismutase in tumorigenesis.

Cammarota F, de Vita G, Salvatore M, Laukkanen MO.

Biomed Res Int. 2015;2015:780409. doi: 10.1155/2015/780409. Epub 2015 Oct 15.

5.

FAS Death Receptor: A Breast Cancer Subtype-Specific Radiation Response Biomarker and Potential Therapeutic Target.

Horton JK, Siamakpour-Reihani S, Lee CT, Zhou Y, Chen W, Geradts J, Fels DR, Hoang P, Ashcraft KA, Groth J, Kung HN, Dewhirst MW, Chi JT.

Radiat Res. 2015 Nov;184(5):456-69. doi: 10.1667/RR14089.1. Epub 2015 Oct 21.

6.

H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.

Paschall AV, Yang D, Lu C, Choi JH, Li X, Liu F, Figueroa M, Oberlies NH, Pearce C, Bollag WB, Nayak-Kapoor A, Liu K.

J Immunol. 2015 Aug 15;195(4):1868-82. doi: 10.4049/jimmunol.1402243. Epub 2015 Jul 1.

7.

Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity.

Cao K, Wang G, Li W, Zhang L, Wang R, Huang Y, Du L, Jiang J, Wu C, He X, Roberts AI, Li F, Rabson AB, Wang Y, Shi Y.

Oncogene. 2015 Dec 3;34(49):5960-70. doi: 10.1038/onc.2015.46. Epub 2015 Mar 9.

8.

Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors.

Wajapeyee N, Malonia SK, Palakurthy RK, Green MR.

Genes Dev. 2013 Oct 15;27(20):2221-6. doi: 10.1101/gad.227413.113. Epub 2013 Oct 8.

9.

Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity.

Banik D, Khan AN, Walseng E, Segal BH, Abrams SI.

PLoS One. 2012;7(9):e45422. doi: 10.1371/journal.pone.0045422. Epub 2012 Sep 19.

10.

Targeting apoptosis signaling pathways for anticancer therapy.

Fulda S.

Front Oncol. 2011 Aug 27;1:23. doi: 10.3389/fonc.2011.00023. eCollection 2011.

11.

Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma.

Zhang CZ, Chen GG, Merchant JL, Lai PB.

Cell Cycle. 2012 Jan 15;11(2):322-34. doi: 10.4161/cc.11.2.18758. Epub 2012 Jan 15.

12.

Targeting tyrosine kinases and autophagy in prostate cancer.

Kung HJ.

Horm Cancer. 2011 Feb;2(1):38-46. doi: 10.1007/s12672-010-0053-3. Epub 2010 Dec 2. Review.

13.

siRNA Down-regulation of the PATZ1 Gene in Human Glioma Cells Increases Their Sensitivity to Apoptotic Stimuli.

Tritz R, Mueller BM, Hickey MJ, Lin AH, Gomez GG, Hadwiger P, Sah DW, Muldoon L, Neuwelt EA, Kruse CA.

Cancer Ther. 2008;6(B):865-876.

14.

Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects.

Liu TC, Castelo-Branco P, Rabkin SD, Martuza RL.

Mol Ther. 2008 Jun;16(6):1041-7. doi: 10.1038/mt.2008.58. Epub 2008 Apr 1.

15.

Targeting cell death in tumors by activating caspases.

MacKenzie SH, Clark AC.

Curr Cancer Drug Targets. 2008 Mar;8(2):98-109. Review.

16.
17.

Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo.

Achachi A, Florins A, Gillet N, Debacq C, Urbain P, Foutsop GM, Vandermeers F, Jasik A, Reichert M, Kerkhofs P, Lagneaux L, Burny A, Kettmann R, Willems L.

Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10309-14. Epub 2005 Jul 8.

19.

Immune evasion by murine melanoma mediated through CC chemokine receptor-10.

Murakami T, Cardones AR, Finkelstein SE, Restifo NP, Klaunberg BA, Nestle FO, Castillo SS, Dennis PA, Hwang ST.

J Exp Med. 2003 Nov 3;198(9):1337-47. Epub 2003 Oct 27.

Supplemental Content

Support Center